Meetings

This webinar is the first in a two-part CAR T webinar series and will highlight two talks from the 2025 Tandem Meetings.

This interactive webinar will highlight key research abstracts featured at the 2025 Tandem Meetings of ASTCT and CIBMTR. 

This webinar consists of two 30-minute journal club presentations, each including 20 minutes for the presentation and 10 minutes for discussion and a Q&A session. In the September Journal Club session, Drs. Yi and Trinh will present two articles related to 1) enhanced CAR T-cell therapy for lymphoma after previous failure and 2) linvoseltamab for the treatment of relapsed/refractory multiple myeloma.

The Clinical Education Conference (CEC) provides a deeper understanding of the diagnostic evaluations and therapeutic treatments for acute and chronic complications of hematopoietic cell transplantation and cellular therapies. 

As we prepare for upcoming changes in 2026, the webinar will provide clarity on the purpose and evolving standards of the RFI, its connection to payer-provider relationships and its integration with CIBMTR data.

The goals of the conference are to review the state of the science and basic, translational and clinical research related to relapse after allogeneic and autologous HSCT, along with cellular therapies.